Table 2.
Subtypes of cancer versus non-cancer ISP
| No cancer (n = 1,227) | Lung (n = 12) | Prostate (n = 10) | Colorectal (n = 7) | Breast (n = 7) | Gyn. cancer (n = 5) | CUP (n = 4) | Lymphoma (n = 4) | |
|---|---|---|---|---|---|---|---|---|
| Age | 69.5 ± 15.1 | 68.4 ± 11.2 | 75.2 ± 12.4 | 74.6 ± 14.6 | 76.5 ± 8.9 | 71.7 ± 13.7 | 62.4 ± 5.4 | 71.6 ±12.6 |
| Male, n (%) | 694 (56.6) | 6 (50.0) | 10 (100.0) | 5 (71.4) | 1 (14.3) | − | 4 (100.0) | 3 (75.0) |
| Median NIHSS (IQR) | 3 (1 – 8) | 5 (1 – 8) | 4 (3 – 9) | 3 (0 – 9) | 2 (2 – 3) | 5 (4 – 7) | 3 (2 – 7.5) | 7 (4.5 – 10) |
| Median mRS (IQR) | 2 (1 – 4) | 2 (1 – 4) | 1.5 (1 – 3) | 2 (2 – 4) | 2 (2 – 3) | 1 (1 – 1) | 2 (81.5 – 2) | 2.5 (1.5 – 3) |
| Median time from stroke to cancer (IQR), months | − | 8.7 (5.5 – 27.3) | 14.0 (6.0 – 20.3) | 4.0 (1.3 – 22.0) | 12.2 (8.1 – 25.8) | 14.3 (2.2 – 18.1) | 16.8 (7.1 – 23.8) | 15.9 (12.4 – 20.1) |
| Smoking, n (%) | 664 (54.1) | 10 (83.3)* | 7 (70.0) | 5 (71.4) | 3 (42.9) | 3 (60.0) | 4 (100)** | 2 (50.0) |
| Blood values | ||||||||
| Fibrinogen, mmol/l | 3.7 ± 1.1 | 4.0 ± 1.5 | 4.3 ± 1.6 | 9.2 ± 13.6** | 4.5± 2.1 | 3.7 ± 0.4 | 3.6 ± 0.4 | 3.5 ±0.8 |
| Hemoglobin, g/dl | 14.3 ± 1.5 | 13.9 ± 2.2 | 14.0 ± 1.9 | 13.5 ± 2.8 | 13.2 ± 2.0 | 13.9 ± 1.8 | 14.8 ± 1.3 | 14.1 ±0.9 |
| Cholesterol, mmol/l | 5.3 ± 1.3 | 5.2 ± 1.4 | 5.0 ± 1.0 | 4.9 ± 1.5 | 5.0 ± 1.7 | 5.0 ± 1.3 | 5.5 ± 0.4 | 5.2 ±1.4 |
| D-dimer, mg/l | 1.4 ± 2.5 | 3.7 ± 6.3* | 1.7 ± 1.4 | 1.0 ± 1.1 | 1.8± 2.7 | 3.5 ± 4.8 | − | 3.0 ±1.8 |
| CRP, mg/l | 10.0 ± 26.4 | 29.7 ± 68.4* | 14.3 ± 33.7 | 12.3 ± 21.3 | 25.6± 34.8 | 31.6 ± 59.5 | 3.5 ± 2.5 | 3.0 ±1.8 |
| Glucose, mmol/l | 6.7 ± 2.5 | 8.2 ± 4.6* | 6.2 ± 1.3 | 6.7 ± 1.5 | 6.7 ± 2.8 | 6.5 ± 1.8 | 8.1 ± 2.0 | 6.2 ±1.8 |
Values are expressed as mean ± SD, unless otherwise specified.
*
p ≤ 0.05
**
p ≤ 0.01.